Psychiatry and Neurology, Neurology · Los Angeles, CA
NPI
1588683395
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
300 Medical Plaza, #b200
Los Angeles, CA, 90095
Phone (310) 794-1195
Groups this clinician bills Medicare through
Medicare paid, 2024
$59K
637 services
Medicare patients, 2024
252
Average age 68
Drug cost, 2024
$9.2M
839 prescriptions
Company payments, 2025
$593K
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Perry B Shieh was code 99215 (office e&m - established), 184 times for 112 patients. In total Perry B Shieh billed 637 services in 29 codes, and Medicare paid $59K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-01-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 184 | 112 | $142.51 | $26K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 139 | 99 | $13.70 | $1,904 |
| 99214 Office E&M - Established | Office | 102 | 83 | $97.30 | $9,925 |
| 99205 Office E&M - New | Office | 31 | 31 | $153.93 | $4,772 |
| 99233 Hospital E&M - Subsequent | Facility | 25 | 11 | $97.49 | $2,437 |
| 99223 Hospital E&M - Initial | Facility | 23 | 23 | $133.72 | $3,076 |
| 99222 Hospital E&M - Initial | Facility | 14 | 14 | $107.42 | $1,504 |
| 99213 Office E&M - Established | Office | 12 | 12 | $77.12 | $925 |
By year: 2022 $47K for 419 services; 2023 $47K for 410 services; 2024 $59K for 637 services.
Medicare prescription drug claims, 2024
In 2024, the drug Perry B Shieh prescribed most often to Medicare patients was Gammagard Liquid (Immun Glob G(Igg)/Gly/Iga Ov50), with 212 prescriptions and refills. In total Perry B Shieh wrote 839 Medicare prescriptions that cost $9.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gammagard Liquid Immun Glob G(Igg)/Gly/Iga Ov50 | 212 | 216 | 12 | $2.7M |
| Mycophenolate Mofetil Generic | 79 | 176 | 23 | $17K |
| Gamunex-C Immune Globul G/Gly/Iga Avg 46 | 76 | 76 | Under 11 | $998K |
| Prednisone Generic | 65 | 107 | 16 | $486 |
| Evrysdi Risdiplam | 48 | 49 | Under 11 | $1.3M |
| Privigen Immun Glob G(Igg)/Pro/Iga 0-50 | 41 | 41 | Under 11 | $284K |
| Pyridostigmine Bromide Generic | 34 | 63 | 14 | $2,550 |
| Octagam Immun Globg(Igg)/Malt/Iga Ov50 | 25 | 25 | Under 11 | $233K |
| Sodium Chloride 0.9 % Sodium Chloride | 23 | 25 | Under 11 | $133 |
| Gammaplex Immun Glob G(Igg)/Gly/Iga 0-50 | 22 | 22 | Under 11 | $370K |
| Gabapentin Generic | 18 | 48 | Under 11 | $365 |
| Gammaked Immune Globul G/Gly/Iga Avg 46 | 17 | 17 | Under 11 | $328K |
| Epinephrine Generic | 13 | 13 | 12 | $4,084 |
| Zilbrysq Zilucoplan Sodium | 13 | 13 | Under 11 | $465K |
| Nexviazyme Avalglucosidase Alfa-Ngpt | 12 | 12 | Under 11 | $588K |
Brand drugs: 567 claims; generic drugs: 272 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Perry B Shieh $593K ($588K in general payments such as food, travel and fees and $5,005 for research) from 23 companies. The largest payer was Sarepta Therapeutics, Inc. with $201K.
| Company | Payments | Amount |
|---|---|---|
| Sarepta Therapeutics, Inc. SRPT | 54 | $201K |
| Alexion Pharmaceuticals, Inc. AZN | 177 | $126K |
| UCB, Inc. UCB.BR | 130 | $83K |
| Biogen, Inc. BIIB | 36 | $52K |
| Argenx US, Inc. ARGX | 39 | $36K |
| Genentech USA, Inc. ROG.SW | 33 | $26K |
| Amgen Inc. AMGN | 12 | $12K |
| ITF Therapeutics LLC | 11 | $11K |
| Catalyst Pharmaceuticals, Inc. CPRX | 8 | $9,582 |
| CSL Behring CSL.AX | 11 | $8,016 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.